ADMP insider filings

Adamis Pharmaceuticals Corp — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-30. Screen ADMP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ADMP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Adamis Pharmaceuticals Corp

FiledFormInsiderReported transactionsSource
2023-05-304Versi Ebrahim — CEO, DirectorGrant/award (A): 8,745 · Grant/award (A): 177,194 · Grant/award (A): 20,577 (derivative) · Grant/award (A): 20,577 (derivative) · Grant/award (A): 20,577 (derivative) · Grant/award (A): 20,577 (derivative) · +2 moreEDGAR
2023-05-304Versi Jannine — DirectorGrant/award (A): 177,194 · Grant/award (A): 5,144 (derivative) · Grant/award (A): 5,144 (derivative) · Grant/award (A): 5,144 (derivative) · Grant/award (A): 5,144 (derivative) · Grant/award (A): 5,144 (derivative) · +1 moreEDGAR
2023-05-304Desai Meera J. — DirectorGrant/award (A): 3,138EDGAR
2022-11-164BIRNDORF HOWARD C — DirectorDisposition to issuer (D): 58,824 (derivative) · Grant/award (A): 58,824 (derivative)EDGAR
2022-05-274CARLO DENNIS J PHDOption exercise (M): 250,000 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2022-05-264REED VICKIE S — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-224Benedicto David C. — Chief Financial OfficerSale (S): 3,603 @ $0.61EDGAR
2022-03-224Moss Ronald B. — Chief Medical OfficerSale (S): 8,199 @ $0.60EDGAR
2022-03-224Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 11,859 @ $0.60EDGAR
2022-03-224CARLO DENNIS J PHD — President & CEO, DirectorSale (S): 10,490 @ $0.60EDGAR
2021-12-034Benedicto David C. — Chief Financial OfficerSale (S): 13,554 @ $0.79EDGAR
2021-12-034Moss Ronald B. — Chief Medical OfficerSale (S): 35,553 @ $0.79EDGAR
2021-12-034Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 50,757 @ $0.79EDGAR
2021-12-034CARLO DENNIS J PHD — President & CEO, DirectorSale (S): 47,870 @ $0.79EDGAR
2021-10-064Desai Meera J. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2021-02-234Moss Ronald B. — Chief Medical OfficerOption exercise (M): 13,911 · Option exercise (M): 13,911 (derivative) @ $0EDGAR
2021-02-234Marguglio David J. — SVP and Chief Business Officer, DirectorOption exercise (M): 22,258 · Option exercise (M): 22,258 (derivative) @ $0EDGAR
2021-02-234Hopkins Robert O — Chief Financial OfficerOption exercise (M): 22,258 · Option exercise (M): 22,258 (derivative) @ $0EDGAR
2021-02-234CARLO DENNIS J PHD — President & CEO, DirectorOption exercise (M): 27,822 · Option exercise (M): 27,822 (derivative) @ $0EDGAR
2020-11-244Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 35,000 @ $0.40EDGAR
2020-11-244Hopkins Robert O — Chief Financial OfficerSale (S): 35,000 @ $0.41EDGAR
2020-11-204Moss Ronald B. — Chief Medical OfficerSale (S): 8,532 @ $0.41EDGAR
2020-11-204Daniels Karen K. — VP of OperationsSale (S): 5,333 @ $0.41EDGAR
2020-11-204Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 8,532 @ $0.41EDGAR
2020-11-204Hopkins Robert O — Chief Financial OfficerSale (S): 7,229 @ $0.41EDGAR
2020-11-204CARLO DENNIS J PHD — President & CEO, DirectorSale (S): 10,665 @ $0.41EDGAR
2020-10-014Hopkins Robert O — Chief Financial OfficerSale (S): 20,000 @ $0.80EDGAR
2020-10-014Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 20,000 @ $0.80EDGAR
2020-08-204Moss Ronald B. — Chief Medical OfficerSale (S): 8,749 @ $0.87EDGAR
2020-08-204Daniels Karen K. — VP of OperationsSale (S): 5,480 @ $0.87EDGAR
2020-08-204Marguglio David J. — SVP and Chief Business Officer, DirectorSale (S): 8,749 @ $0.87EDGAR
2020-08-204Hopkins Robert O — Chief Financial OfficerSale (S): 7,418 @ $0.87EDGAR
2020-08-204CARLO DENNIS J PHD — President & CEO, DirectorSale (S): 10,929 @ $0.87EDGAR

Recent 8-K events — Adamis Pharmaceuticals Corp

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-07-018-K2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
EDGAR
2024-02-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-02-058-K1.03 — Bankruptcy or Receivership
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-318-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-01-238-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-038-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-038-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2023-12-218-K1.02 — Termination of a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-048-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2023-11-288-K1.02 — Termination of a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ADMP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs